Deciphering immune mechanisms in chronic inflammatory demyelinating polyneuropathies.

Abstract

Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease of the peripheral nerves that presents with either chronic progression or relapsing disease. Recent studies in samples from patients with CIDP and mouse models have delineated how defects in central (thymic) and peripheral (extrathymic) immune tolerance mechanisms can cause PNS autoimmunity. Notably, nerve parenchymal cells actively contribute to local autoimmunity and also control disease outcome. Here, we outline how emerging technologies increasingly enable an integrated view of how immune cells and PNS parenchymal cells communicate in CIDP. We also relate the known heterogeneity of clinical presentation with specific underlying mechanisms. For example, a severe subtype of CIDP with tremor is associated with pathogenic IgG4 autoantibodies against nodal and paranodal proteins. An improved understanding of pathogenic mechanisms in CIDP will form the basis for more effective mechanism-based therapies.

• Authors: Jolien Wolbert, Mandy I Cheng, Gerd Meyer zu Horste, Maureen A Su
• Journal: JCI insight (JCI Insight) Vol. 5 Issue 3 (02 13 2020) ISSN: 2379-3708 [Electronic] United States
• PMID: 32051341 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Autoantibodies
• Immunoglobulin G

Topics

• Animals
• Autoantibodies (immunology)
• Disease Models, Animal
• Humans
• Immunoglobulin G (immunology)
• Mice
• Peripheral Nerves (pathology)
• Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (immunology)